Kala Pharmaceuticals Ownership | Who Owns Kala Pharmaceuticals?
Kala Pharmaceuticals Ownership Summary
Kala Pharmaceuticals is owned by 4.12% insiders, and 95.88% retail investors. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.90% of its assets in Kala Pharmaceuticals shares.
KALA Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Kala Pharmaceuticals | - | 4.12% | 95.88% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Specialty & Generic Drug Manufacturers Stocks | 26.69% | 10.91% | 62.39% |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 1 | - | 1 | - | - | - | - | - | - | - |
Sep 30, 2024 | 1 | - | 1 | - | - | - | - | - | - | - |
Jun 30, 2024 | 1 | - | 1 | - | - | - | - | - | - | - |
Mar 31, 2024 | 1 | - | 1 | - | - | - | - | - | - | - |
Dec 31, 2023 | 1 | - | 1 | - | - | - | - | - | - | - |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 115.44K | 1.90% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 36.40K | 0.60% | 10.10K |
Vifag 2002 SICAV | 20.00K | 0.43% | - |
Vanguard US Total Market Shares ETF | 26.44K | 0.41% | - |
Fidelity Extended Market Index | 20.09K | 0.31% | -128.00 |
BlackRock Extended Equity Market K | 9.24K | 0.20% | -4.00 |
Extended Equity Market Fund K | 9.14K | 0.14% | 28.00 |
Fidelity Total Market Index | 8.33K | 0.13% | - |
NT Ext Equity Mkt Idx Fd - L | 5.50K | 0.09% | 2.86K |
Fidelity Series Total Market Index | 5.00K | 0.08% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jan 06, 2025 | Kharabi Darius | CHIEF BUSINESS OFFICER | Sell | $15.42K |
Jan 06, 2025 | Bazemore Todd | SEE REMARKS | Sell | $15.21K |
Jan 06, 2025 | Brazzell Romulus K | SEE REMARKS | Sell | $18.66K |
Jan 06, 2025 | Iwicki Mark T | CHIEF EXECUTIVE OFFICER | Sell | $44.09K |
Jan 06, 2025 | Reumuth Mary | CHIEF FINANCIAL OFFICER | Sell | $13.02K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | 5 |
2024 Q4 | 2 | - |
2024 Q2 | - | 10 |
2024 Q1 | - | 6 |
2023 Q2 | - | - |
KALA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools